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Large numbers of Mycobacterium tuberculosis isolates that were obtained from patients’ sputa on diagnosis
and during follow-up after short-course chemotherapy in Madras, India. have either no copy or only a single
copy of IS6110. This poses a limitation for DNA fingerprinting with an IS6110-based probe to determine the
frequency of exogenous reinfection versus that of endogenous reactivation. In the present study, we overcame
this limitation by using an alternate probe, the direct-repeat element. Comparison of pre- and posttreatment
isolates by direct-repeat restriction fragment length polymorphism analysis indicated a high degree of endo-
genous reactivation among patients who have relapses after the successful completion of chemotherapy.
The pandemic of human immunodeficiency virus (HIV) in-
fection has resulted in an increase in the incidence of tuber-
culosis in many countries. Evidence indicating an increased
rate of recurrence of tuberculosis in HIV-infected patients
treated with certain regimens has been reported (7). Contro-
versy prevails regarding the relative importance of endogenous
reactivation and exogenous reinfection as the cause of recur-
rent pulmonary tuberculosis. While epidemlological data ob-
tained from south Indian Mycobacterium bovis BCG trials have
suggested that the former is more important the latter cannot
be ruled out because of the high degree of endemicity of
tuberculosis in countries like India. Hence. monitoring the
control of tuberculosis by epidemiological investigation is of
the utmost importance. Fingerprinting by restriction fragment
length polymorphism (RFLP) analysis has been a useful tool
for studying the epidemiology of tuberculosis.
RFLP with the widely reported IS6110-based probe has
been considered an excellent tool for tracing the transmission
of particular strains of Mycobacterium tuberculosis during out-
breaks (4, 5). Recently, IS6110 was successfully used to trace
exogenous reinfection with multidrug-resistant M. tuberculosis
In patients with advanced HIV infection (10). Although most
of the M. tuberculosis strains carry multiple copies of IS6110.
strains with a single copy or no copy have been reported in
many countries (6, 13). Hence, it becomes imperative to use an
alternate probe like the direct-repeat (DR) probe. which is a
DR element from M. bovis BCG, to overcome the limitations
of IS6110. We have used the DR probe to fingerprint isolates
obtained from patients pretreatment and after a relapse to
determine the frequency of exogenous reinfection versus the
rare of endogenous reactivation in Madras in southern India.
The pretreatment and relapse isolates of M. tuberculosis
used in the study were obtained from patients with pulmonary
tuberculosis included in controlled clinical trials conducted at
the Tuberculosis Research Centre, Madras. The isolates orig-
- -
inated from 52 patients who had undergone short-course che-
motherapy for 6 or 8 months. The initial isolate was obtained
before starting treatment. and the subsequent isolate was ob-
t ined after stopping treatment. Patients with quiescent dis-
ease at the end of chemotherapy were followed for as long as
60 months by monthly sputum examination for up to 24 months
from the start of treatment and at 3-month intervals thereafter
in order to determine the stability of bacteriological quiescence
and the relapse rates. A patient was classified as having had a
bacteriological relapse (true relapse) if two or more positive
cultures were obtained during a 6-month period. A culture was
consid red to be an isolated positive culture if there was no
other positive culture in the previous 6 months or in the suc-
ceeding 6 months (11).
The isolates were grown in Middlebrook 7H9 medium con-
taining 0.05% Tween 80 and 5% albumin-glucose complex at
37°C. DNA was prepared as described by Baess (1). The DNAs
extracted from the isolates were subject IO restriction digestion
overnight at 37°C with AluI. The fragments were separated
electrophoretically, transferred to charged nylon membranes.
and hybridized with the probe. The experiments were con-
ducted twice to confirm the results. The 36-mer DR sequence
(DR-r: 5’ -GTTTCCGTCCCCTCTCGGGGTTTTGGGTCT
GACGAC-3’) of M. bovis BCG (8) was synthesized (Applied
Bio System). This probe was labelled with fluorescein-dUTP by
using ECL-3’ oligo labelling and detection system (Amersham
International plc, Buckinghamshire, United Kingdom).
Coded samples of 52 pairs of clinical isolates obtained pre-
treatment and titer a relapse were used in the analysis. Eight
clinical isolates from these 52 pairs (either pretreatment or
posttreatment ) were omitted from the analysis because of par-
tial digestion of DSA. Hence, a total of 44 pairs of clinical
isolates or 96 [(44 X 2)- 8)] individual clinical isolates were
analyzed by RFLP with DR. On analysis of these 96 individual
clinical isolates with the DR probe. 30 different patterns were
observed, and the number of bands ranged from two to seven.
On the basis of the number and the molecular sizes of the
bands, similar RFLP patterns were grouped. After decoding
the samples, 29 of 44 posttreatment isolates were classified as
true relapse isolates, while 15 isolates were classified as iso-
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FIG. 1. DNAs from strains with a single copy of IS6110 digested with Alu1 and probed with DR showing multiple bands. Lane 1, bacteriophage lambda HindIII
marker:lanes2 to25, clinical isolates
lated positive isolates. Among the 29 true relapse isolates, the
banding patterns of 20 isolates matched those of their corre-
sponding pretreatment isolates. and the remaining 9 true re-
lapse isolates showed patterns different from those of their
pretreatment counterparts. Of the 15 isolated positive isolates,
2 isolates showed patterns that matched those of their pretreat-
ment counterparts and the remaining 13 isolates showed pat-
terns dissimilar to those of their original pretreatment coun-
terparts (Table 1). Among the isolated positive patients, the
infecting strain was new in a greater percentage than that
noted among the patients with true relapses. The difference
between the pretreatment and posttreatment isolates among
patients with relapses could arise because of laboratory cross
 contamination or mixed infections. In order to rule out mixed
infections, we fingerprinted tie clones cultured from each of
the 10 randomized sputum samples by using the DR probe. All
five clones of each isolate showed similar patterns.
In a study being submitted separately, we report that more
than 40% of the clinical isolates of M. tuberculosis from Madras
have either no copy or a single copy of IS6110 (3). Thirty such
clinical isolates that had only a single copy of IS6110 were
fingerprinted by using DR. DR-RFLP showed two to seven
bands, whereas a single band was found with the IS6110 probe
(Fig. i). Among these 30 isolates, 17 different patterns were
observed. Similarly, four isolates which were negative for
IS6110 showed multiple bands with the DR probe. van Soolin-
gen et al. (12) have reported that multiple bands could be
resolved for strains with a single copy of IS6110. Our results
are imilar, thus confirming the observations of van Soolingen
t al. (12).
The controversy regarding exogenous reinfection in previ-
ously infected patients has existed for several decades (9).
Howev r, it was thought to occur rarely because of the immu-
nity conferred by the initial infection. RFLP studies conducted
in Hong Kong showed that the patterns for 88% of the isolates
from patients with relapses matched those for their pretreat-
ment counterparts. indicating a high frequency, of occurence
of infections caused by endogenous reactivation of M. uber-
culosis (2). Our present study showed a similar trend in that the
patterns for 695 of the isolates from patients with relapses
mat hed those for pretreatment isolates.
S all et al. (10) have reported that among the M. tubercu-
losis strains from 11 HIV-positive patients who were infected
by strains which developed resistance to antimicrobial agents,
the RFLP patterns of six strains remained essentially un-
changed, despite the development of drug resistance. Our ob-
servations also indicate that the RFLP patterns obtained with
the DR probe have no correlation with drug susceptibility or
resistance.
In summary, the present study was designed to show the
utility of RFLP with the DR probe in characterizing the rate of
M. tub rculosis reinfection versus the rate of reactivation.
Th se data suggest that among the patient population studied,
the rate of relapse caused by reactivation exceeds the rate of
relapse caused by reinfection.
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